PIK3CA and metastatic malignant neoplasm: Table 2 shows the estrogen receptor, progesterone receptor, and HER2 status of the six patients for which PIK3CA mutation status was determined. The elapsed time between patient diagnosis (both cancer diagnosis and metastatic cancer diagnosis) and the bone metastasis biopsy is also shown in Table 2.